SECOND AMENDMENT TO LOAN AGREEMENTLoan Agreement • December 8th, 2022 • Evolus, Inc. • Pharmaceutical preparations • New York
This SECOND AMENDMENT TO LOAN AGREEMENT (this “Amendment”), dated and effective as of December 5, 2022 (the “Effective Date”), is made by and among EVOLUS, INC., a Delaware corporation (as “Borrower” and a Credit Party), BIOPHARMA CREDIT PLC, a public limited company incorporated under the laws of England and Wales with company number 10443190 (as the “Collateral Agent”), BPCR LIMITED PARTNERSHIP, a limited partnership established under the laws of England and Wales with registration number LP020944 (as a “Lender”) and BIOPHARMA CREDIT INVESTMENTS V (MASTER) LP, a Cayman Islands exempted limited partnership acting by its general partner, BioPharma Credit Investments V GP LLC (as a “Lender”).
